Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 193 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

The Differential Risk of Cervical Cancer in HPV-Vaccinated and -Unvaccinated Women: A Mathematical Modeling Study.
Naslazi E, Hontelez JAC, Naber SK, van Ballegooijen M, de Kok IMCM
Cancer Epidemiol Biomarkers Prev, 30(5):912-919, 09 Apr 2021
Cited by: 0 articles | PMID: 33837119 | PMCID: PMC8102319
Add to export list Free full text in Europe PMC
Identifying key factors for the effectiveness of pancreatic cancer screening: A model-based analysis.
Koopmann BDM, Harinck F, Kroep S, Konings ICAW, Naber SK, Lansdorp-Vogelaar I, Fockens P, van Hooft JE, Cahen DL, van Ballegooijen M, Bruno MJ, de Kok IMCM
Int J Cancer, 149(2):337-346, 25 Mar 2021
Cited by: 6 articles | PMID: 33644856 | PMCID: PMC8251934
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.
Burger EA, de Kok IMCM, Groene E, Killen J, Canfell K, Kulasingam S, Kuntz KM, Matthijsse S, Regan C, Simms KT, Smith MA, Sy S, Alarid-Escudero F, Vaidyanathan V, van Ballegooijen M, Kim JJ
J Natl Cancer Inst, 112(9):955-963, 01 Sep 2020
Cited by: 36 articles | PMID: 31821501 | PMCID: PMC7492768
Add to export list Free full text in Europe PMC
Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study.
Jansen E, Naber SK, Aitken CA, de Koning HJ, van Ballegooijen M, de Kok I
BJOG, 128(3):573-582, 29 Jul 2020
Cited by: 25 articles | PMID: 32638462 | PMCID: PMC7818441
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.
Simms KT, Yuill S, Killen J, Smith MA, Kulasingam S, de Kok IMCM, van Ballegooijen M, Burger EA, Regan C, Kim JJ, Canfell K
Gynecol Oncol, 158(3):710-718, 26 Jul 2020
Cited by: 12 articles | PMID: 32723676 | PMCID: PMC8723888
Add to export list Free full text in Europe PMC
Adding insult to injury: Effects of chronic oxybenzone exposure and elevated temperature on two reef-building corals.
Wijgerde T, van Ballegooijen M, Nijland R, van der Loos L, Kwadijk C, Osinga R, Murk A, Slijkerman D
Sci Total Environ, 733:139030, 04 May 2020
Cited by: 11 articles | PMID: 32446051
Add to export list
The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology.
de Kok IMCM, Burger EA, Naber SK, Canfell K, Killen J, Simms K, Kulasingam S, Groene E, Sy S, Kim JJ, van Ballegooijen M
Med Decis Making, 40(4):474-482, 01 May 2020
Cited by: 8 articles | PMID: 32486894 | PMCID: PMC7322998
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.
Gini A, Jansen EEL, Zielonke N, Meester RGS, Senore C, Anttila A, Segnan N, Mlakar DN, de Koning HJ, Lansdorp-Vogelaar I, EU-TOPIA consortium
Eur J Cancer, 127:224-235, 10 Jan 2020
Cited by: 74 articles | PMID: 31932176
Add to export list Review
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.
Zielonke N, Gini A, Jansen EEL, Anttila A, Segnan N, Ponti A, Veerus P, de Koning HJ, van Ravesteyn NT, Heijnsdijk EAM, EU-TOPIA consortium
Eur J Cancer, 127:191-206, 10 Jan 2020
Cited by: 56 articles | PMID: 31932175
Add to export list Review
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review.
Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, Ivanuš U, McKee M, de Koning HJ, de Kok IMCM, EU-TOPIA consortium
Eur J Cancer, 127:207-223, 21 Jan 2020
Cited by: 95 articles | PMID: 31980322
Add to export list Review
Adding insult to injury: Effects of chronic oxybenzone exposure and elevated temperature on two reef-building corals
Wijgerde T, van Ballegooijen M, Nijland R, van der Loos L, Kwadijk C, Osinga R, Murk A, Slijkerman D
bioRxiv, 20 Dec 2019
Cited by: 0 articles | PPR: PPR106246
Add to export list Preprint
Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential.
Naber SK, Kundu S, Kuntz KM, Dotson WD, Williams MS, Zauber AG, Calonge N, Zallen DT, Ganiats TG, Webber EM, Goddard KAB, Henrikson NB, van Ballegooijen M, Janssens ACJW, Lansdorp-Vogelaar I
JNCI Cancer Spectr, 4(1):pkz086, 14 Oct 2019
Cited by: 28 articles | PMID: 32025627 | PMCID: PMC6988584
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.
Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I, Dutch National Colorectal Cancer Screening Working Group
Clin Gastroenterol Hepatol, 18(7):1493-1500, 20 Aug 2019
Cited by: 22 articles | PMID: 31442598
Add to export list
Pancreatic cyst surveillance imposes low psychological burden.
Overbeek KA, Kamps A, van Riet PA, Di Marco M, Zerboni G, van Hooft JE, Carrara S, Ricci C, Gonda TA, Schoon E, Polkowski M, Beyer G, Honkoop P, van der Waaij LA, Casadei R, Capurso G, Erler NS, Bruno MJ, Bleiker EMA, [...] PACYFIC study group
Pancreatology, 19(8):1061-1066, 05 Sep 2019
Cited by: 4 articles | PMID: 31582346
Add to export list
Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.
Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I
Clin Chem, 65(3):419-426, 16 Jan 2019
Cited by: 5 articles | PMID: 30651228
Add to export list
The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
Matthijsse SM, Naber SK, Hontelez JAC, Bakker R, van Ballegooijen M, Lansdorp-Vogelaar I, de Kok IMCM, de Koning HJ, van Rosmalen J, de Vlas SJ
PLoS One, 13(9):e0202924, 04 Sep 2018
Cited by: 7 articles | PMID: 30180203 | PMCID: PMC6122803
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Colorectal Cancer: Cost-effectiveness of Colonoscopy versus CT Colonography Screening with Participation Rates and Costs.
van der Meulen MP, Lansdorp-Vogelaar I, Goede SL, Kuipers EJ, Dekker E, Stoker J, van Ballegooijen M
Radiology, 287(3):901-911, 27 Feb 2018
Cited by: 23 articles | PMID: 29485322 | PMCID: PMC6716164
Add to export list Free full text in Europe PMC
Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
van den Broek JJ, van Ravesteyn NT, Mandelblatt JS, Cevik M, Schechter CB, Lee SJ, Huang H, Li Y, Munoz DF, Plevritis SK, de Koning HJ, Stout NK, van Ballegooijen M
Med Decis Making, 38(1_suppl):112S-125S, 01 Apr 2018
Cited by: 8 articles | PMID: 29554471 | PMCID: PMC5862068
Add to export list Free full text in Europe PMC
Quality of life assumptions determine which cervical cancer screening strategies are cost-effective.
de Kok IMCM, Korfage IJ, van den Hout WB, Helmerhorst TJM, Habbema JDF, Essink-Bot ML, van Ballegooijen M
Int J Cancer, 142(11):2383-2393, 08 Feb 2018
Cited by: 10 articles | PMID: 29349795
Add to export list
Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer.
Meester RGS, Doubeni CA, Zauber AG, van Ballegooijen M, Corley DA, Lansdorp-Vogelaar I
Int J Cancer, 141(11):2359-2367, 31 Aug 2017
Cited by: 4 articles | PMID: 28815573 | PMCID: PMC5890914
Add to export list Free full text in Europe PMC
Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.
Naber SK, Kuntz KM, Henrikson NB, Williams MS, Calonge N, Goddard KAB, Zallen DT, Ganiats TG, Webber EM, Janssens ACJW, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I
Gastroenterology, 154(1):105-116.e20, 28 Sep 2017
Cited by: 14 articles | PMID: 28964749 | PMCID: PMC6104831
Add to export list Free full text in Europe PMC
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I, Goede SL, Bosch LJW, Melotte V, Carvalho B, van Engeland M, Meijer GA, de Koning HJ, van Ballegooijen M
Clin Gastroenterol Hepatol, 16(4):504-512.e11, 18 Jul 2017
Cited by: 19 articles | PMID: 28733262 | PMCID: PMC5773413
Add to export list Free full text in Europe PMC
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
Goede SL, Rabeneck L, van Ballegooijen M, Zauber AG, Paszat LF, Hoch JS, Yong JH, Kroep S, Tinmouth J, Lansdorp-Vogelaar I
PLoS One, 12(3):e0172864, 15 Mar 2017
Cited by: 26 articles | PMID: 28296927 | PMCID: PMC5351837
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
Rozemeijer K, Naber SK, Penning C, Overbeek LI, Looman CW, de Kok IM, Matthijsse SM, Rebolj M, van Kemenade FJ, van Ballegooijen M
BMJ, 356:j504, 14 Feb 2017
Cited by: 14 articles | PMID: 28196844 | PMCID: PMC5421440
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis.
Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C
Clin Gastroenterol Hepatol, 15(9):1471-1474, 12 Jan 2017
Cited by: 15 articles | PMID: 28089850 | PMCID: PMC5507756
Add to export list Free full text in Europe PMC

1-25 of 193 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Partnerships & funding